| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.42 | 5e-10 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.27 | 6e-09 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |